Michael M. Frank
#93,653
Most Influential Person Now
Michael M. Frank's AcademicInfluence.com Rankings
Michael M. Frankbiology Degrees
Biology
#4381
World Rank
#6537
Historical Rank
Immunology
#183
World Rank
#191
Historical Rank

Download Badge
Biology
Why Is Michael M. Frank Influential?
(Suggest an Edit or Addition)Michael M. Frank's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Practice parameter for the diagnosis and management of primary immunodeficiency. (2015) (638)
- Hereditary angioedema: the clinical syndrome and its management. (1976) (576)
- Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. (1977) (530)
- The role of complement in inflammation and phagocytosis. (1991) (507)
- Sjögren's syndrome (Sicca syndrome): current issues. (1980) (499)
- Treatment of Hereditary Angioedema with Danazol (1976) (495)
- Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. (1979) (485)
- Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. (1984) (376)
- Nodular lymphoma--evidence for origin from follicular B lymphocytes. (1974) (358)
- Inhibition of the complement cascade by the major secretory protein of vaccinia virus. (1990) (319)
- 8. Hereditary angioedema. (2008) (317)
- Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. (1996) (302)
- Aerosol α1 -antitrypsin treatment for cystic fibrosis (1991) (291)
- Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. (1985) (276)
- Plasma fibronectin enhances phagocytosis of opsonized particles by human peripheral blood monocytes (1983) (275)
- Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects. (1981) (262)
- Practice parameter for the diagnosis and management of primary immunodeficiency. (2005) (259)
- Non-endemic Burkitts's lymphoma. A B-cell tumor related to germinal centers. (1976) (246)
- Therapeutic potential of complement modulation (2010) (224)
- Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. (1976) (220)
- C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha (1988) (219)
- Complement and bacteria: chemistry and biology in host defense. (1984) (216)
- Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. (1980) (215)
- International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. (2012) (206)
- Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites. (1972) (206)
- Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell lines. (1972) (205)
- C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma. (1987) (200)
- Pathophysiology of Immune Hemolytic Anemia (1977) (195)
- Receptors for immunoglobulin and complement on human alveolar macrophages. (1975) (194)
- Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation. (1995) (193)
- A prospective clinical and immunologic analysis of patients with serum sickness. (1984) (178)
- Opsonic requirements for intravascular clearance after splenectomy. (1981) (178)
- Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade. (1986) (177)
- Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis. (1986) (172)
- Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model. (1989) (172)
- The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. (1974) (171)
- Acquired C1 Esterase Inhibitor Deficiency and Angioedema: A Review (1979) (171)
- Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. (1987) (169)
- A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement. (1974) (161)
- Regulation of complement activity by vaccinia virus complement-control protein. (1992) (160)
- IMPAIRED IMMUNE RESPONSE OF SPLENECTOMISED PATIENTS TO POLYVALENT PNEUMOCOCCAL VACCINE (1981) (159)
- Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. (2010) (159)
- SYSTEMIC CAPILLARY LEAK SYNDROME AND MONOCLONAL IgG GAMMOPATHY: Studies in a Sixth Patient and a Review of the Literature (1977) (149)
- Complement 1 Inhibitor Is a Regulator of the Alternative Complement Pathway (2001) (149)
- Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria (1987) (146)
- Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man. (1974) (145)
- Leukemic reticuloendotheliosis: presence of a receptor for cytophilic antibody. (1974) (144)
- Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies. (1987) (143)
- Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors. (1986) (140)
- A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia. (1982) (140)
- Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2. (1987) (140)
- NIH Conference: Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases. (1983) (133)
- Functional markers: a new perspective on malignant lymphomas. (1977) (132)
- Long-term therapy of hereditary angioedema with danazol. (1980) (131)
- Capsule Production and Growth Phase Influence Binding of Complement to Staphylococcus aureus (2001) (131)
- US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency. (2013) (126)
- Hereditary angioedema: the use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery. (1975) (125)
- Complement activation. (1981) (124)
- Samter's Immunologic Diseases (2001) (124)
- C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I (1984) (121)
- Heterogeneity of immunologic markers and surface morphology in childhood lymphoblastic lymphoma. (1976) (119)
- Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum. (1972) (117)
- The effects of intravenous immune globulin on complement-dependent immune damage of cells and tissues. (1992) (115)
- Aerosol alpha 1-antitrypsin treatment for cystic fibrosis. (1991) (115)
- Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae. (1983) (115)
- IN VITRO STUDIES OF COMPLEMENT FUNCTION IN SERA OF C4-DEFICIENT GUINEA PIGS (1971) (115)
- The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man. (1976) (115)
- The role of complement in the induction of antibody responses. (1983) (107)
- Complement depletion in cryptococcal sepsis. (1978) (107)
- Structural and functional properties of the „hairy”︁ cells of leukemic reticuloendotheliosis (1978) (106)
- Identification of subpopulations of mononuclear cells in cutaneous infiltrates. I. Differentiation between B cells, T cells, and histiocytes. (1973) (106)
- The role of the spleen in experimental pneumococcal bacteremia. (1981) (106)
- The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream. (1983) (104)
- ONTOGENY OF B LYMPHOCYTES (1974) (104)
- Studies on the fibronectin receptors of human peripheral blood leukocytes. Morphologic and functional characterization (1984) (103)
- Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease. (1986) (103)
- Demonstration of circulating immune complexes in Sjögren's syndrome. (1979) (103)
- Hereditary deficiency of the sixth component of complement in man. I. Immunochemical, biologic, and family studies. (1974) (102)
- Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. (1985) (101)
- Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis. (1978) (101)
- The localization of non-microbial antigens in the draining lymph nodes of tolerant, normal and primed rabbits. (1967) (99)
- Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system. (2006) (98)
- Effects of corticosteroids and splenectomy on the immune clearance and destruction of erythrocytes. (1973) (98)
- Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs. (1976) (96)
- Hereditary complement (C2) deficiency with dermatomyositis. (1975) (94)
- Human Serum Sickness: A Prospective Analysis of 35 Patients Treated with Equine Anti‐Thymocyte Globulin for Bone Marrow Failure (1988) (93)
- The critical role of complement in experimental pneumococcal sepsis. (1980) (92)
- US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. (2020) (89)
- Complement receptors. (1981) (89)
- The function of antibody and complement in the lysis of bacteria. (1987) (86)
- A simple method for the determination of complement receptor-bearing mononuclear cells. (1976) (86)
- Hereditary angioedema: the clinical syndrome and its management in the United States. (2006) (85)
- Complement in the pathophysiology of human disease. (1987) (85)
- High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance (1989) (85)
- Recombinant adenovirus vectors activate the alternative complement pathway, leading to the binding of human complement protein C3 independent of anti-ad antibodies. (2004) (85)
- Complement levels and activity in the normal and LPS-injured lung. (2007) (84)
- Studies of human C5a as a mediator of inflammation in normal human skin. (1985) (84)
- Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease. (1980) (81)
- Role of complement in host defense against experimental disseminated candidiasis. (1978) (80)
- Monocyte receptors for the Fc portion of IgG increase in number in autoimmune hemolytic anemia and other hemolytic states and are decreased by glucocorticoid therapy. (1983) (79)
- Similarities of surface characteristics of neoplastic well-differentiated lymphocytes from solid tissues and from peripheral blood. (1976) (79)
- Bactericidal and opsonic properties of C4-deficient guinea pig serum. (1972) (79)
- Antibody-Dependent Lymphoid Cell-Mediated Cytotoxicity: Role of Lymphocytes Bearing a Receptor for Complement (1973) (78)
- Current state of hereditary angioedema management: a patient survey. (2015) (76)
- Complement-immunoglobulin interactions. (1995) (76)
- The complement system in host defense and inflammation. (1979) (75)
- The long-term safety of danazol in women with hereditary angioedema. (1990) (73)
- Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways. (1975) (73)
- Total respiratory support from swine lungs in primate recipients. (1998) (73)
- The fourth component of complement in the cerebrospinal fluid in systemic Lupus erythematosus. (1973) (72)
- A serial study of splenic reticuloendothelial system Fc receptor functional activity in systemic lupus erythematosus. (1982) (71)
- The glomerular complement receptor in immunologically mediated renal glomerular injury. (1976) (71)
- IN VIVO STUDIES IN C4-DEFICIENT GUINEA PIGS (1971) (70)
- Endotoxemia associated with the Jarisch-Herxheimer reaction. (1976) (69)
- Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes. (1996) (69)
- Availability of Complement Bound to Staphylococcus aureus To Interact with Membrane Complement Receptors Influences Efficiency of Phagocytosis (2003) (68)
- Sjögren's syndrome: a defect in reticuloendothelial system Fc-receptor-specific clearance. (1979) (68)
- Response of variant hereditary angioedema phenotypes to danazol therapy. Genetic implications. (1979) (66)
- Generation of isogenic K54 capsule‐deficient Escherichia coli strains through TnphoA‐mediated gene disruption (1993) (66)
- Identification of cells infiltrating the minor salivary glands in patients with Sjögren's syndrome. (1974) (66)
- The relationship between antibody affinity and the efficiency of complement fixation. (1970) (63)
- The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system. (1983) (63)
- Studies of the molecular mechanisms of C3b inactivation and a simplified assay of beta 1H and the C3b inactivator (C3bINA). (1979) (63)
- Effect of cortisone therapy on serum complement components. (1973) (62)
- High doses of intravenous Ig inhibit in vitro uptake of C4 fragments onto sensitized erythrocytes (1991) (61)
- Immunoregulatory disorders associated with hereditary angioedema. II. Serologic and cellular abnormalities. (1986) (60)
- The Role of Late Complement Components and the Alternate Complement Pathway in Experimental Cryptococcosis (1973) (60)
- Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation. (1973) (59)
- High doses of intravenous Ig inhibit in vitro uptake of C4 fragments onto sensitized erythrocytes. (1991) (59)
- Defective reticuloendothelial system Fc-receptor function in patients with acquired immunodeficiency syndrome. (1985) (58)
- Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9. (1985) (57)
- Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. (1985) (56)
- Characterization of C1q receptor expression on human phagocytic cells: effects of PDBu and fMLP. (1986) (56)
- A new simplified procedure for C1 inhibitor purification. A novel use for jacalin-agarose. (1989) (56)
- Human C5a modulates monocyte Fc and C3 receptor expression. (1985) (56)
- Localization of receptors for activated complement on visceral epithelial cells of the human renal glomerulus. (1977) (55)
- Acquired angioedema: observations on the mechanism of action of autoantibodies directed against C1 esterase inhibitor. (1988) (55)
- Complement-independent clearance of IgG-sensitized erythrocytes: inhibition by cortisone. (1974) (55)
- New therapies for hereditary angioedema: disease outlook changes dramatically. (2008) (55)
- Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition. (1983) (55)
- Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity. (1985) (54)
- C3d receptors are expressed on human monocytes after in vitro cultivation. (1983) (54)
- Clq acts synergistically with phorbol dibutyrate to activate CR1‐mediated phagocytosis by human mononuclear phagocytes (1988) (54)
- Wild-type adenoviruses from groups A–F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent (2008) (54)
- Decay-accelerating factor is present on paroxysmal nocturnal hemoglobinuria erythroid progenitors and lost during erythropoiesis in vitro (1985) (53)
- C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2 (1988) (53)
- A quantitative fluorescent method for measurement of bacterial adherence and phagocytosis. (1986) (53)
- A new complement-mediated cytolytic mechanism--the C1-bypass activation pathway. (1973) (52)
- Immunoglobulin and complement receptors on human eosinophils and their role in cellular adherence to schistosomules. (1977) (51)
- The role of complement in the localization of pneumococci in the splanchnic reticuloendothelial system during experimental bacteremia. (1981) (51)
- Complement Factor H Autoantibodies Are Associated with Early Stage NSCLC (2010) (51)
- The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation. (1982) (50)
- Effect of sulfones on complement deposition in dermatitis herpetiformis and on complement-mediated guinea-pig reactions. (1976) (49)
- Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data. (2016) (49)
- Relationship of serum complement levels to events of the malarial paroxysm. (1974) (48)
- Studies on phagocytosis in patients with acute bacterial infections. (1989) (48)
- A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4. (1984) (48)
- Oral manifestations and dental management of patients with hereditary angioedema. (1991) (47)
- Immunoglobulin in the control of complement action (2000) (47)
- Heparan Sulfate, Including That in Bruch’s Membrane, Inhibits the Complement Alternative Pathway: Implications for Age-Related Macular Degeneration (2010) (47)
- Classical complement pathway activation by antipneumococcal antibodies leads to covalent binding of C3b to antibody molecules (1983) (47)
- Bypassing complement: evolutionary lessons and future implications. (2006) (47)
- The effect of Bacillus Calmette-Guerin-induced macrophage activation on the in vivo clearance of sensitized erythrocytes. (1974) (47)
- Expression of human complement factor H prevents age-related macular degeneration-like retina damage and kidney abnormalities in aged Cfh knockout mice. (2015) (46)
- STUDIES ON THE TERMINAL STEPS OF IMMUNE HEMOLYSIS. I. INHIBITION BY TRISODIUM ETHYLENEDIAMINETETRAACETATE (EDTA). (1964) (45)
- Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus. (1987) (45)
- Monocyte receptors for the Fc portion of IgG studies with monomeric human IgG1: normal in vitro expression of Fc gamma receptors in HLA-B8/Drw3 subjects with defective Fc gamma-mediated in vivo clearance. (1982) (45)
- Lack of binding of human C3, in its native state, to C3b receptors. (1981) (45)
- Immunologic reactivity in the hypereosinophilic syndrome. (1979) (45)
- Evaluation of the adverse effects of long-term hyposensitization. (1978) (43)
- THE SUBUNITS IN RABBIT ANTI-FORSSMAN IGM ANTIBODY (1968) (43)
- Phagocytosis of target particles bearing C3b-IgG covalent complexes by human monocytes and polymorphonuclear leucocytes. (1987) (43)
- Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage. (1983) (43)
- Bactericidal but not nonbactericidal C5b-9 is associated with distinctive outer membrane proteins in Neisseria gonorrhoeae. (1985) (42)
- The reticuloendothelial system and bloodstream clearance. (1993) (42)
- TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivity (1993) (41)
- Characterization of the hematopoietic defect in paroxysmal nocturnal hemoglobinuria. (1986) (41)
- The effect of temperature on the reactivity of guinea-pig complement with gamma G and gamma M haemolytic antibodies. (1970) (41)
- Monocyte receptors for the Fc portion of IgG are increased in systemic lupus erythematosus. (1984) (41)
- The mechanism by which microorganisms avoid complement attack (1992) (40)
- C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from salmonellae. (1987) (40)
- Before and after, the impact of available on-demand treatment for HAE. (2015) (40)
- Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway. (1973) (40)
- Tumor-promoting phorbol esters induce rapid internalization of the C3b receptor via a cytoskeleton-dependent mechanism. (1985) (40)
- Monokines released during short-term Fc gamma receptor phagocytosis up-regulate polymorphonuclear leukocytes and monocyte-phagocytic function. (1991) (39)
- Primary Biliary Cirrhosis and the Complement System (1979) (39)
- Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency (2016) (39)
- Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo. (2010) (39)
- Serum complement activation in central nervous system disease in Sjögren's syndrome. (1988) (38)
- The effects of IL-1, IL-2, and tumor necrosis factor on polymorphonuclear leukocyte Fc gamma receptor-mediated phagocytosis. IL-2 down-regulates the effect of tumor necrosis factor. (1991) (38)
- Complement resistance in microbes (2005) (38)
- The complement fragment C3d facilitates phagocytosis by monocytes. (1987) (37)
- Hereditary angioneurotic edema of the gastrointestinal tract. (1972) (37)
- C1q enhances the phagocytosis of Cryptococcus neoformans blastospores by human monocytes. (1988) (37)
- Complement disorders and hereditary angioedema. (2010) (37)
- Receptors for immunoglobulin and complement on mouse leukemias and lymphomas. (1972) (36)
- Paroxysmal nocturnal hemoglobinuria. Alternate-complement-pathway-mediated lysis induced by magnesium. (1973) (36)
- Demonstration of defective C3-receptor-mediated clearance by the reticuloendothelial system in patients with acquired immunodeficiency syndrome. (1987) (35)
- STUDIES ON THE TERMINAL STEPS OF IMMUNE HEMOLYSIS. II. RESOLUTION OF THE E TRANSFORMATION REACTION INTO MULTIPLE STEPS. (1964) (34)
- Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide (1984) (33)
- Contributions of the classical and alternate complement pathways to the biological effects of endotoxin. (1973) (33)
- Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. I. Antibody and serum requirements. (1973) (33)
- Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing. (1987) (33)
- Effect of sex hormones on the complement-related clinical disorder of hereditary angioedema. (1979) (31)
- Serum complement and immunity in experimental simian malaria. II. Preferential activation of early components and failure of depletion of late components to inhibit protective immunity. (1975) (31)
- IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111 (1985) (31)
- Hereditary angioedema from the patient's perspective: A follow-up patient survey. (2018) (31)
- Host defense against bacterial endotoxemia-contribution of the early and late components of complement to detoxification. (1972) (31)
- Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia. (2004) (31)
- Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide. (1982) (31)
- Cutaneous manifestations of serum sickness in patients receiving antithymocyte globulin. (1985) (30)
- Danazol-induced cystitis: an undescribed source of hematuria in patients with hereditary angioneurotic edema. (1986) (30)
- C3b binding, but not its breakdown, is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from Salmonellae. (1986) (30)
- Serum complement and immunity in experimental simian malaria. I. Cyclical alterations in C4 related to schizont rupture. (1975) (30)
- Circulating immune complexes and glomerulonephritis in a patient with congenital absence of the third component of complement. (1983) (30)
- Deposition of complement components in the cutaneous lesions of chronic mucocutaneous candidiasis. (1976) (30)
- Humoral immunostimulation. IV. Role of complement (1975) (29)
- Analysis of complement-dependent antibody-mediated lysis of target cells acutely infected with measles. (1976) (29)
- Binding sites for immune complexes containing IgG in the renal interstitium. (1979) (28)
- Mixed cryoglobulinemia: association of glomerulonephritis with defective reticuloendothelial system Fc receptor function. (1979) (28)
- Membrane attack complex of complement in rheumatoid synovial tissue demonstrated by immunofluorescent microscopy. (1986) (27)
- Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization. (1988) (26)
- Complement-mediated tissue damage: contribution of the classical and alternate complement pathways in the Forssman reaction. (1972) (25)
- Serum sickness and haematopoietic recovery with antithymocyte globulin in bone marrow failure patients (1986) (25)
- Multiple types of immune complexes in patients with mixed cryoglobulinemia. (1980) (25)
- Production of congenital malformations using tissueantisera. 8. Effectiveness of reduced, alkylated and digested anti-kidney antibodies. (1970) (25)
- Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro. (1983) (24)
- Human eosinophil adherence to serum-treated sepharose: granule-associated enzyme release and requirement for activation of the alternative complement pathway. (1977) (24)
- Biotinylation of human C3. (1982) (24)
- Biosynthesis of the second (C2) and fourth (C4) components of complement in vitro by tissues isolated from guinea-pigs with genetically determined C4 deficiency. (1972) (24)
- Di George syndrome associated with glioma and two kinds of viral infection. (1977) (24)
- Update on preventive therapy (prophylaxis) of hereditary angioedema. (2011) (23)
- IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model. (1999) (23)
- Surfactant protein A enhances the phagocytosis of C1q-coated particles by alveolar macrophages. (2002) (23)
- Activator-bound C1 is less susceptible to inactivation by C1 inhibition than is fluid-phase C1. (1986) (23)
- Antibody-dependent lymphoid cell-mediated cytotoxicity: role of complement. (1974) (23)
- High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance. (1989) (23)
- The immune adherence receptor: dissociation between the expression of erythrocyte and mononuclear cell C3b receptors. (1975) (23)
- Hereditary angiodema: a current state-of-the-art review, VI: novel therapies for hereditary angioedema. (2008) (22)
- C1‐esterase inhibitor and a novel peptide inhibitor improve contractile function in reperfused skeletal muscle (2003) (22)
- Production of chemotactic activity by guinea pig immunoglobulins following activation of the C3 complement shunt pathway. (1972) (21)
- Terminal Complement Complexes (SC5b‐9) in Cerebrospinal Fluid in Autoimmune Nervous System Diseases (1988) (21)
- Reviews of Infectious Diseases (2016) (21)
- Surface receptors of human neoplastic lymphoreticular cells. (1977) (21)
- A study of human serum sickness. (1985) (21)
- The alternate complement pathway in cell damage: antibody-mediated cytolysis of erythrocytes and nucleated cells. (1972) (20)
- Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registry. (2017) (20)
- Complement in clinical medicine. (1975) (20)
- Annihilating host defense (2001) (20)
- Generation of chemotactic factors in guinea pig serum via activation of the classical and alternate complement pathways. (1973) (19)
- Prevention of hyperacute xenograft rejection by intravenous immunoglobulin. (1995) (19)
- Reticuloendothelial system fc receptor function in rheumatoid arthritis. (1983) (18)
- Novel Adenovirus Vectors ‘Capsid-Displaying’ a Human Complement Inhibitor (2010) (17)
- High doses of intravenous immunoglobulin do not affect the recognition phase of the classical complement pathway (1991) (17)
- Quantitation of activation of the human terminal complement pathway by ELISA. (1985) (17)
- Activation of the Alternate Complement Pathway by Human Immunoglobulins (1976) (16)
- The role of complement in host resistance to bacteria (2005) (16)
- Hereditary angioedema: a half century of progress. (2004) (16)
- Reduced concentrations of the first component of complement in hypogammaglobulinemia: Correction by infusion of γ-globulin (1978) (16)
- Cleavage of membrane-bound C3b and C3bi by viable human neutrophils (PMN). (1983) (16)
- Inherited deficiencies of complement and complement-related proteins. (1986) (16)
- Abdominal pain in hereditary angioedema: the role of acid hypersecretion. (1989) (14)
- CD21 deficiency, complement, and the development of common variable immunodeficiency. (2012) (14)
- Observations on the mechanism of immune hemolysis: importance of immunoglobulin class and source of complement on the extent of damage. (1970) (14)
- Complement receptor expression by neoplastic and normal human cells. (1983) (14)
- Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen. (1989) (14)
- Recombinant and Plasma-Purified Human C1 Inhibitor for the Treatment of Hereditary Angioedema (2010) (14)
- Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients. (2017) (14)
- Role of complement in the pathophysiology of hematologic diseases. (1977) (13)
- Complement Deficiencies of Laboratory Animals (1981) (13)
- Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes. (1983) (13)
- The effect of synthetic androgens in hereditary angioneurotic edema: alteration of C1 inhibitor and C4 levels. (1976) (13)
- Complement: a brief review. (1989) (13)
- Subcutaneous infusion of human C1 inhibitor in swine. (2010) (13)
- Detection of complement in relation to disease. (1992) (12)
- High dose intravenous immunoglobulin does not affect complement-bacteria interactions. (1998) (12)
- A Receptor for Activated C3 in the Normal and Abnormal Human Renal Glomerular Capillary Wall (1976) (12)
- Interactions of monomeric IgG bearing covalently bound C3b with polymorphonuclear leucocytes. (1987) (12)
- Cold agglutinins and cold-agglutinin disease. (1977) (12)
- A simplified method for purification of human C5a from citrated plasma. (1986) (12)
- Animal models for complement deficiencies (1995) (11)
- Complement factor 1 inhibitor improves cardiopulmonary function in neonatal cardiopulmonary bypass. (2007) (11)
- Metabolic behavior of C3 in normal, C4-deficient (C4D) and cortisone-treated guinea pigs. (1974) (11)
- The use of conglutinin in a quantitative assay for the presence of cell-bound C3bi and evidence that a single molecule of C3bi is capable of binding conglutinin. (1982) (11)
- Update on preventive therapy (prophylaxis) for hereditary angioedema. (2013) (11)
- Reticuloendothelial clearance of radiolabelled pneumococci in experimental bacteremia: correlation of changes in clearance rates, sequestration patterns, and opsonization requirements at different phases of the bacterial growth cycle. (1981) (11)
- Studies on behavior. V. Actions of l-epinephrine and related compounds. (1959) (11)
- Deficiencies of the Complement System (2014) (11)
- Studies of antibody and complement function in host defense against bacterial infection. (1987) (10)
- Urine-histamine levels in patients with hereditary angioedema (HAE). (1988) (9)
- Anticomplement receptor activity in the serum of patients with primary biliary cirrhosis. (1986) (9)
- Patients with bone marrow failure demonstrate decreased cutaneous reactivity to human C5a. (1987) (9)
- An Overview of Novel Therapies for Acute Hereditary Angioedema (2010) (9)
- Activation of the C3b receptor: effect of diacylglycerols and calcium mobilization. (1985) (9)
- Purification of C1 inhibitor. A new approach for the isolation of this biologically important plasma protease inhibitor. (1987) (9)
- Complement Activation Influences Staphylococcus aureus Adherence to Endothelial Cells (2003) (9)
- High doses of intravenous immunoglobulin do not affect the recognition phase of the classical complement pathway. (1991) (9)
- Complement and the control of HIV infection: an evolving story (2014) (9)
- Linkage of C4 Deficiency to the Major Histocompatibility Locus in the Guinea Pig (1976) (8)
- Factor I co-factor activity of CR1 overcomes the protective effect of IgG on covalently bound C3b residues. (1985) (8)
- Increased expression of Fc gamma RI on isolated PMN from individuals of African descent. (1993) (8)
- Deficiency in C3b receptors on neutrophils of patients with chronic granulomatous disease and hyperimmunoglobulin-E recurrent infection (Job's) syndrome (1984) (8)
- Immune complexes and the treatment of biliary cirrhosis. (1979) (8)
- Increased expression of FcγRI on isolated PMN from individuals of African descent (1993) (8)
- Site of deposition of C3 in Arthus reactions of C4 deficient guinea pigs. (1973) (8)
- Hereditary angioedema: short-term prophylaxis for surgery. (2012) (8)
- Genius at work: Osler's 1888 article on hereditary angioedema. (2010) (8)
- C1 esterase inhibitor: clinical clues to the pathophysiology of angioedema. (1986) (8)
- sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor. (2020) (8)
- Studies of Human C 5 a as a Mediator of Inflammation in Normal Human Skin (8)
- Immune Complexes: Normal Physiology and Role in Disease (2009) (7)
- Studies of complement-mediated membrane damage: the influence of erythrocyte storage on susceptibility to cytolysis. (1973) (7)
- Some Sources of Error in the Akerfeldt Test for Serum Oxidative Activity.∗ (1958) (7)
- Immune Adherence by the Alternate Complement Pathway (1972) (7)
- Immunostimulation of tumor cell growth: role of complement (1974) (7)
- Hereditary C6 deficiency in man. (1973) (7)
- Skin graft rejection and the arthus reaction in mice deficient in the third component (c'3) of complement. Abstr. (1965) (7)
- Mechanisms by which HIV envelope minimizes immunogenicity (2011) (7)
- Failure of cytotoxic agents to inhibit the clearance of sensitized erythrocytes. (1974) (7)
- Complement activation by IgG containing immune complexes regulates the interaction of C1q with its ligands. (2019) (6)
- Complement Fixation by a Single Molecule of γG Hemolysin (1970) (6)
- Spontaneous re-aggregation of IgM subunits and restoration of antibody activity after reduction and alkylation of rabbit anti-Forssman antibody. (1969) (6)
- Studies of phagocytosis in chronic granulomatous disease (1987) (6)
- A sensitive specific hemolytic assay for proenzyme C1. (1987) (6)
- Hereditary angio-oedema (1993) (6)
- CR1-receptor recycling in phorbol ester-activated polymorphonuclear leucocytes. (1988) (6)
- Complement inclinical medicine (1975) (6)
- The oxidative activity of blood serum in schizophrenic and manic-depressive psychoses. (1958) (6)
- Distribution of complement receptors on human normal and malignant mononuclear cells. (1980) (6)
- Homozygous C1 inhibitor deficiency: The conclusion of a long search. (2006) (6)
- Linkage of the gene controlling the synthesis of the fourth component of complement to the major histocompatibility complex of the guinea pig (1976) (6)
- Evidence that rabbit gamma G haemolysin in capable of utilizing guinea-pig complement more efficiently than rabbit gamma M haemolysin. (1970) (6)
- Mechanism of bacterial resistance to serum killing (1982) (6)
- Urticaria (Hives) and Angioedema (2011) (5)
- New developments in immunopathology with special reference to complement and immune complexes. (1985) (5)
- C1 inhibitor therapy and hereditary angioedema. (2010) (5)
- Protease inhibitors of human plasma. C1-inhibitor (C1-INH). (1985) (5)
- Immune Complexes and Allergic Disease (2009) (5)
- Decline in rates of clearance of IgG-sensitized erythrocytes with increasing age. (1988) (5)
- Terminal complement components play a role in the expression of C5a. (1987) (4)
- Evasion of host defenses: group report. (1980) (4)
- Fc-receptor dysfunction in lupus. (1979) (4)
- Reduced concentrations of the first component of complement in hypotammaglobulinemia: correction of infusion of gamma-globulin. (1978) (4)
- Binding of IgG-sensitized erythrocytes by mitral and aortic cardiac valves: a possible clue to the pathogenesis of immune valvular heart disease. (1981) (4)
- Heparan Sulfate in Human Bruch’s Membrane/Choroid Tissue Increases the Rate of Proteolytic Cleavage of C3b by factors H and I (2009) (4)
- The role of complement in the in vivo destruction of erythrocytes. (1980) (4)
- Molecular Mechanisms in the Antibacterial Action of Complement (1986) (4)
- Hereditary angioedema: implications of treating a rare disease. (2012) (4)
- Studies of Immunologic Function in C4 Deficient Guinea Pigs (1971) (4)
- Investigation of the Interactions Between Complement Factor H, C3b, and Amyloid β (2008) (4)
- Complement and Hemolytic Antibody: Changes in Their Activity Induced by Mercaptoethanol (1965) (4)
- Isolation and characterization of a novel plasma protein which binds to activated C4 of the classical complement pathway. (1989) (3)
- Inherited deficiency of C8 in a patient with recurrent meningococcal infections: Further evidence for a dysfunctional C8 molecule and nonlinkage to the HLA system (2004) (3)
- Danazol in the Treatment of Hereditary Angioedema (1980) (3)
- A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition. (1987) (3)
- C3b Inactivator: The Effect on Cell Bound C3b and a Simplified Functional Assay (1978) (3)
- Renal Failure in Paroxysmal Hemoglobinuria (1974) (2)
- Immune Complexes and Complement: Their Role in Host Defense and in Disease (2009) (2)
- The C1 esterase inhibitor and hereditary angioedema (1982) (2)
- Salmonella and Complement: The Critical Influence of O-Polysaccharide within LPS (1988) (2)
- The Role of Complement in Host Defense Against Bacteremia (1978) (2)
- Production and characterization of the monoclonal antibody against SGP120, a novel serum protein. (1996) (2)
- The nature of allergy. (1968) (2)
- Complement and arthritis: another step in understanding (2008) (2)
- The relationship of complement to allergic disease. (1969) (2)
- Haemophilus influenzae type b meningitis in a fully immunized 2-year-old. (2002) (2)
- 38 – Immune Complex–Mediated Diseases (2014) (2)
- Complement deficiencies. (2000) (1)
- Human serum sickness. (1984) (1)
- The "neurotic" edema: the parent disease and its offspring. (2002) (1)
- Electrophoretic differentiation of acquired angioedema from hereditary angioedema. (1987) (1)
- Erratum to: Mechanisms by which HIV envelope minimizes immunogenicity (2011) (1)
- Complement receptors and histamine degradation. (1980) (1)
- Mechanism of antibody dependent serum killing of escherichia coli o 111b 4 (1982) (1)
- Unraveling the Complement System and its Mechanism of Action (2014) (1)
- Molecular Mimicry in the Pathogenicity of Microorganisms (1993) (1)
- Evasion Strategies of Microorganisms (1989) (1)
- Evidence for a New Cytotoxic Mechanism: The C1 Bypass Activator Pathway (1973) (1)
- Purification and Metabolism of C1 Inhibitor and its Phenotypic Variants (1978) (1)
- Diagnosis and Treatment of an American Cohort of Patients with Hereditary Angioedema (HAE) Type III (2011) (1)
- 103 – Complement in Control of Infectious Agents (2018) (1)
- Studies on the mechanism of Staphylococcus resistance to complement-mediated killing—Terminal complement components C7, C8 and C9 are deposited and released from Reynolds without causing bacterial death (2007) (1)
- THE COMPLEMENT SYSTEM IN CLINICAL DIAGNOSIS (1979) (1)
- Biological Interactions of Complement with Endotoxin: Studies in C4-Deficient Guinea Pigs (1973) (1)
- Studies of the biologic effects of selective C4 deficiency. (1975) (1)
- Hereditary angioedema: The rewards of studying a rare disease (2004) (1)
- Antibody Responses to a T Cell Dependent Antigen in C4 Deficiency (1978) (1)
- Antibody dependent lymphoid cell mediated cytotoxicity. Abstr. (1972) (1)
- Letter: Renal failure in paroxysmal hemoglobinuria. (1974) (1)
- Monocyte fc receptors for immuno globulin g studied with monomeric iodine 125 labeled immuno globulin g 1 normal fcr expression in hla b 8 drw 3 individuals (1982) (0)
- The reticuloendothelial system and autoimmune disease in man. (1985) (0)
- Modulation of complement-mediated tissue injury by IVIG (1997) (0)
- The Effects of Heparin and Heparan Sulfate on the Complement Regulatory Activity of Factor H (2006) (0)
- Supplementary Material for: Novel Adenovirus Vectors ‘Capsid-Displaying’ a Human Complement Inhibitor (2017) (0)
- IgG Fc Receptor Activity in vivo is Under Complement Control (2012) (0)
- Binding of immunoglobulin- and complement-coated erythrocytes to human neutrophil subpopulations (1981) (0)
- Blocking Complement-Mediated Hemolysis Using RNA Aptamers That Bind Complement Component C8. (2005) (0)
- Functional Analysis of the Y402H Variant of Complement Factor H: Implications for Risk of Age–Related Macular Degeneration. (2006) (0)
- Introduction: New Perspectives in Hereditary Angioedema (HAE): Molecular Mechanisms & Therapeutic Choices: A CME Symposium Presented at the 2009 World Allergy Congress, Buenos Aires, Argentina, December 9, 2009 (2010) (0)
- Mechanism of the Damage‐Producing Steps of Immune Haemolysis (2008) (0)
- Blocking Complement-Mediated Hemolysis of PNH Erythrocytes by RNA Aptamers to C8 and C9. (2004) (0)
- vivo clearance High-dose intravenous immunoglobulin modifies complement-mediated in (2011) (0)
- Evasion mechanisms of bacteria. (2006) (0)
- Anti-complement receptors in PBC in the clearance of complement coated cells in primary biliary cirrhosis (2006) (0)
- 2,3,7,8-tetrachlorodibenzo-p-dioxin and natural immunity: lack of an effect on the complement system in a guinea pig model. (2001) (0)
- Forssman shock in C2-deficient (C2D) guinea pigs: Role of a C2-bypass pathway (1998) (0)
- Mechanism of Complement Activation By PF4/ Heparin Complexes (2016) (0)
- 104 Cutaneous manifestations of human serum sickness (1985) (0)
- SUPPLEMENT Recombinant and Plasma-Purified Human C 1 Inhibitor for the Treatment of Hereditary Angioedema (2015) (0)
- Book ReviewAn Introduction to the Neurosciences. (1972) (0)
- Book ReviewClinical Immunology Update: Reviews for physicians (1980) (0)
- Editorial Complement and arthritis: another step in understanding (2008) (0)
- 1012. Ad Interactions with the Complement Systems of Humans and Mice (2004) (0)
- Control of Complement-Mediated Tissue Damage by γ-Globulin: Application in Xenotransplantation (1997) (0)
- Development of humanized complement factor H transgenic mice to interrogate the effect of age-related macular degeneration risk associated variants in vivo (2012) (0)
- The Function of the Reticuloendothelial System in Autoimmune Disease (1983) (0)
- Recycling of CR1 by phorbol ester-activated polymorphonuclear leukocytes (PMN) (1986) (0)
- Guinea Pig Model Functionally Active C 2-Bypass Pathway in a Damage in the Absence of C 2 : Evidence of a IgG and Complement-Mediated Tissue (1999) (0)
- Studies of the interaction of antibody and complement with encapsulated bacteria. (1986) (0)
- An IGG FC fragment peptide blocks interaction of IGG with C1Q (2000) (0)
- Concentration and Composition Changes in Heparan Sulfate Increase Complement Activation Through Modulation of C3bBb Convertase Formation and This Effect is Modified by Factor H (2011) (0)
- 93 A novel approach for the purification of Cl-inhibitor from human plasma (1983) (0)
- Structure of MntC from cyanobacteria (2005) (0)
- The role of C1 in the regulation of immune complex binding to FcγRIIA (2007) (0)
- Detection of DAF-RBC in PNH Blood (2003) (0)
- Transient deficiency of complement factor D function in infancy (2005) (0)
- I I . RELATIVE RATES OF APPEARANCE OF LYMPHOCYTES BEARING SURFACE IMMUNOGLOBULIN AND COMPLEMENT RECEPTORS BY MICHAEL C. GELFAND,* (2003) (0)
- Efficacy and Safety of a C1 Esterase Inhibitor Concentrate for Long-Term Prophylaxis in Hereditary Angioedema: Findings from a Large International Registry (2015) (0)
- Complement fixation by a single molecule of gamma G hemolysin. (1970) (0)
- F.105. C1q and the Classical But Not Alternative Complement Pathways Control the Binding of Immune Complexes (IC) to IgG Fc Receptors (FcγR) (2006) (0)
- I N Vitro Studies of C O M P L E M E N T Function I N Sera of C 4 -d E F I C I E N T Guinea Pigs (0)
- Monocyte fc receptors for immuno globulin g are increased in auto immune hemolytic anemia (1982) (0)
- Manipulation of the Humoral Immune System and the Host Immune Response to Infection (2001) (0)
- Studies of reticuloendothelial system function in immune complex disease. (1979) (0)
- 407. Complement Blockade Prevents Several Innate Toxicities Rapidly Induced after Intravenous Adenovirus (Ad) Vector Administration (2005) (0)
- Structure determination of proteins involved in the stability of phycobilisomes during environmental stress (2005) (0)
- Immune Complex-Mediated Damage Is Under Complement Pathway Control (2013) (0)
- Role of complement in cold agglutinin disease (1975) (0)
- Age-Related Macular Degeneration Alternative Pathway: Implications for Membrane, Inhibits the Complement Heparan Sulfate, Including That in Bruch's (2010) (0)
- A receptor for activated C3 in the human renal glomerular capillary wall. (1975) (0)
- O N T O G E N Y OF B L Y M P H O C Y T E S I I . RELATIVE RATES OF APPEARANCE OF LYMPHOCYTES BEARING SURFACE IMMUNOGLOBULIN AND COMPLEMENT RECEPTORS (1974) (0)
- Serum Chemotactic Factors in an Animal Model of a Complement Deficiency State (1973) (0)
- INTERACTION OF HELICOBACTER PYLORI (HP) WITH HUMAN COMPLEMENT: 95 (1997) (0)
- Iconographies supplémentaires de l'article : CD21 deficiency, complement, and the development of common variable immunodeficiency (2012) (0)
- Answers for march CME article (1992) (0)
- Evidence that the nurse shark C4 inhibitor is a C1S like molecule (1998) (0)
- Management of Hereditary Angioedema in Childhood: A Review (2014) (0)
- Effect Of Excess Complement Inhibition On AMD-like Pathology Using The APOE4/sCrry Transgenic Murine Model: Does Gain-of-function Worsen Retinal Disease? (2011) (0)
- HEREDITARY ANGIOEDEMA: IDENTIFYING THE CAUSE AND CURE (2013) (0)
- Contributors (2012) (0)
- An Apple a Day Could Keep the Hepatic Abscess Away: A Rare Etiology for a Rare Finding in an Immunocompetent Patient: 831 (2010) (0)
- Modulation of the alternative complement pathway by C1 inhibitor (C1 INH) (2000) (0)
- TABLE I Comparison of Survival in Normal and Splenectomized Guinea Pigs (0)
- The Influence of Heparin, Heparan Sulfate, and C-reactive Protein on the Cofactor Activity of Complement Factor H (402HH and 402YY) (2007) (0)
- MECHANISM OF SERUM RESISTANCE IN BACTERIA Serum (2003) (0)
- Contributors (2018) (0)
- Clinical and laboratorv studies Cutaneous manifestations of serum sickness patients receiving antithymocyte globulin (1985) (0)
- Affect Complement-Bacteria Interactions High Dose Intravenous Immunoglobulin Does Not (1998) (0)
- Enhancing academic allergy/immunology faculty and training programs☆ (1991) (0)
- Erratum: 'Abdominal pain in hereditary angioedema: The role of hypersecretion' (Am. J. Gastroenterol. 84: 873-877, 1989) (1990) (0)
- Biological effects of anti-pneumococcal (Pn) antibody and complement in Pn bacteremia (1982) (0)
- Demonstration of Defective C 3-Receptor-mediated Clearance by the Reticuloendothelial System in Patients with Acquired Immunodeficiency Syndrome (2013) (0)
- 105 – Infectious Complications of Complement Deficiencies (2012) (0)
- Comparison of binding of factors B and H to C3b on Salmonellae differing in their O-antigen polysaccharide (O-PS) structure (1986) (0)
- The classical and alternative complement pathways play different roles in the immune response (2010) (0)
- Hereditary angioedema (2005) (0)
- Influences Efficiency of Phagocytosis Membrane Complement Receptors To Interact with Staphylococcus aureus Availability of Complement Bound to (2003) (0)
- Multimeric complement component C 9 is necessary for killing of Escherichia coli J 5 by terminal attack complex C 5 b9 [ poly ( C 9 ) / complement-mediated bacterial killing ] (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Michael M. Frank?
Michael M. Frank is affiliated with the following schools: